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Cytosolic DNA fragments are recognized as pathogen- and danger-associated molec-
ular patterns that induce a cascade of innate immune responses. Moreover, excessive 
cytosolic DNA can enhance chronic inflammation, predominantly by activating inflam-
masomes, and thereby contributing to the pathogenesis of chronic diseases, such as 
psoriasis. Psoriasis associated non-protein coding RNA induced by stress (PRINS) is 
a long non-coding RNA, which has been shown to be associated with psoriasis sus-
ceptibility and cellular stress responses; however, the precise mechanism of its action 
has not been determined. Here, we provide evidence that, in addition to inflammasome 
activation, cytosolic DNA induces intracellular inflammatory reactions while decreasing 
PRINS gene expression. Furthermore, PRINS overexpression can ameliorate the inflam-
matory-mediator production of keratinocytes induced by cytosolic DNA. Overexpression 
of PRINS resulted in decreased interleukin-6 (IL-6) and chemokine (C–C motif) ligand 
5 (CCL-5) expression and secretion. In silico analysis predicted direct binding sites 
between PRINS and the mRNAs, which was confirmed by an in vitro binding assay and 
on cellular level. Our results indicated that PRINS binds directly to the mRNAs of IL-6 and 
CCL-5 at specific binding sites and eventually destabilizes these mRNAs, leading to a 
decrease in their expression and secretion of the corresponding proteins. These results 
may indicate a restrictive role for PRINS in inflammatory processes.
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inTrODUcTiOn
The skin provides the first line of defense against a variety of environmental, chemical, and physical 
stimuli and acts as an active member of the innate immune system. Double-stranded DNA (dsDNA) 
fragments are known to induce antiviral responses in keratinocytes (1, 2) as well as induce inflam-
masome activation and subsequent interleukin (IL)-1β release in these cells (3, 4). Moreover, 
keratinocytes express a wide range of pattern recognition receptors (PRR) for nucleotide fragments 
(5, 6), mainly implicated in antiviral reactions (2, 6). These PRRs are required for immune response 
in an acute infection and might also lead to the exacerbation of chronic inflammatory inherited mul-
tifactorial diseases, such as psoriasis (7). Psoriasis is caused by the interplay of professional immune 
cells and keratinocytes. Cytosolic nucleotide fragments are highly abundant in psoriatic skin (3), 
leading to chronic activation of professional immune cells (8), and are thought to be an initiator 
factor in the disease. In particular, cytosolic nucleotide fragments do not lead to antiviral reaction, 
but instead activate the AIM2 inflammasome signaling in psoriatic keratinocytes (3), leading to 
prolonged inflammation.
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In the last decade, genome-scale transcription studies have 
uncovered non-coding RNAs as previously unrecognized players 
in the dysregulation of inflammatory reaction in psoriatic skin 
(9, 10). The contribution of both microRNAs (miRNAs) and long 
non-coding RNAs (lncRNAs) to psoriasis has been extensively 
studied (11, 12). We were first to identify a lncRNA potentially 
contributing to disease susceptibility: PRINS, the psoriasis 
susceptibility-related non-coding RNA induced by stress, which 
is highly expressed in psoriatic non-lesional epidermis compared 
both to lesional or healthy epidermis (13). The expression of 
PRINS is modified by a diverse set of cellular stressors, including 
starvation, ultraviolet B (UVB) irradiation, translation inhibition 
(14), and hypoxia (15). Moreover, microbial stimuli decreased 
PRINS expression in macrophages (16) and normal human 
epidermal keratinocytes (NHEKs) (14), and PRINS was recently 
shown to interact with chemokine (C–C motif) ligand 5 (CCL-5, 
also known as RANTES) in kidney epithelial cells (15). CCL-5 
is a chemokine attracting leukocytes to the site of inflammation. 
Under inflammatory conditions, keratinocytes produce large 
amount of CCL-5 to attract antigen-presenting cells (17) and 
T-cells into the epidermis (18); moreover, CCL-5 is overexpressed 
in atopic dermatitis and psoriatic lesions (19). Based on these 
findings, we aimed to investigate whether the PRINS lncRNA 
contributes to keratinocyte innate immune responses.
According to our results, PRINS can ameliorate dsDNA-
induced keratinocyte immune responses. Bioinformatic analysis 
of the PRINS lncRNA sequence revealed putative interaction sites 
for interleukin-6 (IL-6) and CCL-5 mRNAs. Destruction of the 
putative interacting region resulted in the loss of the ability of 
PRINS to bind to the IL-6 mRNA. In addition, our functional 
studies confirmed the regulatory role of the interaction between 
PRINS and IL-6 mRNA. Our results suggest a general anti-
inflammatory function for PRINS and provide insight to the role 
of high PRINS expression in psoriatic non-lesional skin.
MaTerials anD MeThODs
cell culture and inflammatory stimuli
Normal human epidermal keratinocytes used for the experi-
ments were separated from skin specimens obtained from 
the Plastic Surgery Unit of our department. Written informed 
consent was obtained from all investigated individuals. The study 
was approved by the Human Investigation Review Board of the 
University of Szeged and complied with the ethical standards of 
research and in accordance with the Helsinki Declaration.
Epidermis was separated from the dermis by overnight incu-
bation in Dispase (Roche Diagnostics, Manheim, Germany), 
and keratinocytes were obtained after maceration in 0.25% 
trypsin. Cells were grown in 75 cm2 cell-culture flasks and were 
maintained in keratinocyte serum-free medium, containing 
EGF and BPE (Gibco Keratinocyte SFM Kit; Life Technologies, 
Copenhagen, Denmark) and supplemented with 1% antibiotic/
antimycotic solution (PAA Laboratories GmBH, Pasching, 
Austria) and 1% l-glutamine (PAA Laboratories), at 37°C in a 
humidified atmosphere with 5% CO2. The medium was changed 
every 2 days.
Third passage keratinocytes were seeded into 6-well plates. 
Cells were primed in supplement-free medium by addition 
of 5  ng/ml tumor necrosis factor-α (TNF-α) and 5  ng/ml 
interferon-γ (IFN-γ). After 24  h, cells were transfected with 
0.666  µg/ml polydeoxyadenylic acid–polydeoxythymidylic acid 
double-stranded homopolymer [poly(dA:dT), Sigma Aldrich, 
Saint Louis, MO, USA] using the X-tremeGENE 9 DNA transfec-
tion reagent (Roche Diagnostics). Cells were harvested 12 h after 
poly(dA:dT) transfection.
gene-specific Overexpression
For overexpressing PRINS, the AK022045 cDNA sequence 
[Biological Resource Center (NBRC) National Institute of 
Technology and Evaluation, Chiba, Japan] was cloned into a 
pcDNA3.1(+) vector. The empty pcDNA3.1(+) vector served as 
a control.
The ΔPRINS construct was created by replacing the 
AK022045 region (position 538–622) with the following scram-
bled sequence: GTGCGTGGCGGAGACGTGGTGGTAGAC 
C G A A T T G A G G A G G A T C C G A A G G T T A G A C G T 
AGGCGATCGCCGCTTCGGACGCGGTCGC. The ΔPRINS 
sequence was created by GeneArt gene synthesis (Thermo 
Scientific), and cloned into a pcDNA3.1(+) vector.
Transient transfection of NHEK cells was carried out at 
approximately 70% confluency in parallel to cytokine priming, 
using the X-tremeGENE HP DNA transfection protocol, as 
described by the manufacturer (Roche Diagnostics). The transfec-
tion efficiency was 85% on average, as determined by the transfec-
tion of a GFP reporter construct (Lonza, Basel, Switzerland) and 
analysis of GFP expression by flow cytometry. The effectiveness of 
overexpression was investigated with real-time RT-PCR (Figure 
S1 in Supplementary Material).
In Silico Prediction of interacting sites
Sequence complementarity between PRINS (AK022045) and 
the mRNA of IL-1α (M28983.1), IL-1β (NM_000576.2), IL-6 
(NM_000600.4), IL-8 (NM_000584.3), TNF-α (NM_000594.3), 
and CCL-5 (NM_002985.2) was analyzed using two algorithms: 
RIsearch (20), which uses a simplified nearest-neighbor energy 
model, and INTARNA (21–23), which calculates the free-energy 
values of the interaction based on predicted global and local 
structures of mRNAs. The regions predicted by both programs 
were considered as putative interaction sites.
rna isolation and rT-Pcr
Total RNA was isolated from cells using TRIzol® Reagent 
(Invitrogen Corp., Carlsbad, CA, USA), following the manu-
facturer’s instructions. Turbo DNA-free Kit (Ambion, Life 
Technologies) was used for the removal of contaminating DNA. 
cDNA was synthesized from 1  µg total RNA using the iScript 
cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, 
USA). Real-time RT-PCR experiments were carried out with 
the Universal Probe Library system (Roche Diagnostics) using 
a C1000 Touch Thermal Cycler (Bio-Rad Laboratories) and the 
primers listed in Table S1 in Supplementary Material. The expres-
sion of each gene was normalized to the 18S rRNA gene. Relative 
mRNA levels were calculated by the ΔΔCt method.
3Danis et al. PRINS Regulates Immune Responses of Keratinocytes
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1053
elisa
Cell supernatants were centrifuged (5,000 rpm, 4 min, 4°C) to pellet 
cell debris, and the amount of cytokines IL-1α, IL-1β, IL-6, IL-8, 
CCL-5, and TNF-α was determined by ELISA (IL-1α Duo Set, IL-1β 
ELISA Duo Set, and TNF-α Duo Set, R&D Systems, Minneapolis, 
MN, USA; Human IL-6 Mini TMB ELISA Development Kit, 
Human IL-8 TMB ELISA Development Kit, Human RANTES 
ATBS ELISA Development Kit, PeproTech, Rocky Hill, NJ, USA), 
according to the manufacturer’s instructions.
In Vitro Transcription and In Vitro Binding 
assay
PRINS and ΔPRINS RNA sequences were produced by in vitro 
transcription from pcDNA3.1(+) containing the AK022045 
or ΔPRINS cDNA sequence, using Transcript Aid T7 In  Vitro 
Transcription Kit (Thermo Scientific). Products were purified by 
the GeneJET RNA Purification Kit (Thermo Scientific). Quality 
and sequence-length analyses were carried out on reducing 
agarose gel-electrophoresis. The single-stranded RNA products 
were used in a fluorescent binding assay. The fluorescently labeled 
RNA sequence 5′6-carboxyfluorescein(6-FAM)/GAAGCUCUAU 
CUCCCCUCCAGGAGCCCAGCUAUGAACUCCUUCUCC 
ACAAGC GC CUUC GGUC CAGUUGC CUUCUC C CU 
GGGGCUGCUCCUGGUGUUGCCUGCUGCCUUCCCU 
GCC-3′, comprising positions 91–205 of the IL-6 (NM_000600.4) 
mRNA sequence, was produced by Integrated DNA Technologies.
An in vitro binding assay was carried out on a Monolith NT.115 
Pico MicroScale Thermophoresis instrument (NanoTemper 
GmbH, Germany), in nuclease-free water, at 25°C, with 80% 
Laser Power, 10% LED Power, by 2bind GmbH, Regensburg, 
Germany. Fluorescence enhancement of the 6-FAM labeled spe-
cific truncated IL-6 RNA sequence or a 6-FAM labeled unspecific 
DNA, as negative control, was measured after addition of PRINS 
or ΔPRINS. The concentration of fluorescently labeled molecules 
was 10 nM constantly, while unlabeled RNA concentration ranged 
from 126.75 nM to 61.9 pM. Initial fluorescence was analyzed for 
binding curves; the formulation used is displayed in Figure S2 in 
Supplementary Material.
statistical analysis
Experiments were carried out in triplicate with at least three 
biological repeats, as indicated in figure legends. For statistical 
analysis, one-way ANOVA was used to compare more than two 
groups, and one-tailed, paired t-test was used to compare two 
groups. Statistical analysis was carried out using R software, ver-
sion 3.2.2., and the significance level was set at p ≤ 0.05.
resUlTs
Poly(da:dT) Treatment of Keratinocytes 
induces the expression of inflammatory 
cytokines while Decreasing the 
expression of Prins
To study how dsDNA influences NHEKs immune function, we 
analyzed the expression (Figure 1) and secretion (Figure 2) of 
several inflammatory cytokines and the expression of PRINS 
upon poly(dA:dT) exposure.
We confirmed that poly(dA:dT) significantly induced the 
expression and secretion of IL-1β in keratinocytes, as described 
previously (4). In addition, poly(dA:dT) induced very strong 
mRNA expression of IL-1α, IL-6, IL-8, and TNF-α in NHEKs 
(Figures 1B–F).
To gain pronounced inflammatory reaction in NHEKs, a 
priming step using TNF-α and IFN-γ is often applied before 
poly(dA:dT) treatment (3, 4); however, the cumulative effect of 
this treatment on the expression of other cytokines has not been 
examined thoroughly. When cells were primed for 24 h before 
poly(dA:dT) treatment, IL-1β secretion was enhanced by the 
combination of TNF-α and IFN-γ compared to poly(dA:dT) 
treatment alone. In contrast, IL-1β mRNA expression was not 
affected by priming (Figures 1E and 2D). Similarly, priming had 
no effect on TNF-α mRNA expression (Figure  1F). However, 
priming induced significantly higher mRNA expression of the 
other investigated cytokine genes (Figures 1B–D).
In a manner similar to mRNA expression, poly(dA:dT) trans-
fection induced the secretion of the investigated cytokines, and 
the priming step significantly enhanced the amount of secreted 
IL-1α, IL-1β, and IL-8 in the keratinocyte supernatant (Figure 2).
As we and others have demonstrated altered PRINS expression 
upon exposure to inflammatory molecules (14, 16), we examined 
PRINS expression upon poly(dA:dT) treatment. Poly(dA:dT) 
alone or combined with cytokine priming decreased the expres-
sion of PRINS in NHEKs (Figure 1A). The expression of PRINS 
returned to the initial level after 24 h (data not shown), whereas the 
expression of inflammatory cytokines declined during this period.
Prins Overexpression Decreased il-6 
and il-8 levels in Keratinocytes
The change in PRINS expression upon inflammatory stimuli 
suggests the possible contribution of PRINS to inflammatory 
responses of NHEK cells. To determine whether PRINS can 
regulate inflammatory cytokine expression, cells were transfected 
with a construct for overexpressing PRINS during the combined 
priming and poly(dA:dT) treatment. Expression and secretion 
of IL-6 and IL-8 was significantly decreased by PRINS overex-
pression (Figure  3), whereas mRNA expression and secretion 
of IL-1α, IL-1β, and TNF-α were not affected (data not shown). 
These results suggest that PRINS does not influence inflamma-
some activation, but instead influences the regulation of other 
inflammatory processes.
In Silico analysis revealed Putative 
interacting sites between the Prins 
lncrna and the il-6 mrna
The mRNA of the chemokine CCL-5 was previously predicted to 
interact with PRINS; however, it was not reported whether this 
interaction affects the stability of the CCL-5 mRNA (15). Therefore, 
we measured mRNA expression and secretion of CCL-5 during 
PRINS overexpression, and found that both decreased (Figure S3 
in Supplementary Material) in a manner similar to the changes 
observed for IL-6 and IL-8. The similarity of these expression 
FigUre 1 | Poly(dA:dT) treatment decreased the expression of PRINS but induced the expression and secretion of cytokines. Normal human epidermal 
keratinocytes were transfected with poly(dA:dT) for 12 h with or without priming for 24 h with 5 ng/ml tumor necrosis factor-α (TNF)-α and interferon-γ (IFN-γ). RNA 
expression was detected for PRINS (a) and cytokines interleukin-6 (IL-6) (B), IL-8 (c), IL-1α (D), IL-1β (e), TNF-α (F) by real-time RT-PCR. Data are presented as 
mean ± SE of five independent experiments (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001).
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profiles led us to hypothesize similar mechanism(s) for IL-6, IL-8, 
and CCL-5 regulation mediated by PRINS.
To predict interactions between PRINS (AK022045) and the 
mRNAs of IL-6 (NM_00600.4) and IL-8 (NM_000584.3), we per-
formed an in silico analysis using INTARNA (22, 23) and RIsearch 
(20) software. As sequence details of the CCL-5 mRNA and 
PRINS interaction have not been described in detail (15), we also 
included the CCL-5 mRNA (NM_002985.2) in the in silico analysis. 
As a control for the reliability of the prediction analyses, mRNA 
sequences of cytokines not affected by PRINS overexpression (IL-
1α—M28983.1, IL-1β—NM_000576.2, TNF-α—NM_000594.3) 
were also included. The regions predicted by both algorithms 
were considered putative interacting sites. Putative interaction 
sites were not predicted for the cytokines not affected by PRINS 
overexpression (IL-1α, IL-1β, TNF-α) in this analysis. PRINS inter-
action regions were only predicted for the IL-6 and CCL-5 mRNAs 
(Figures 4B,C), two mediators affected by PRINS overexpression. 
A distance of approximately 200 nt separates the predicted inter-
action sites in the PRINS sequence, and the corresponding sites 
occur in the 5′ untranslated region (UTR) of IL-6 and the 3′ UTR 
of CCL-5 (Figure 4A). No interaction site was predicted for IL-8.
Prins Binds to il-6 mrna through Direct, 
sequence-specific interaction
To validate the predicted interaction site, an in  vitro binding 
experiment was carried out using the PRINS lncRNA and 
the IL-6 mRNA. Binding affinity was determined using the 
FigUre 2 | Poly(dA:dT) treatment induced the secretion of cytokines by normal human epidermal keratinocytes (NHEKs). NHEKs were transfected with poly(dA:dT) 
for 12 h with or without priming for 24 h with 5 ng/ml tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). Secretion of cytokines interleukin-6 (IL-6) (a), IL-8  
(B), IL-1α (c), IL-1β (D) was detected by ELISA from cell supernatant. Data are presented as mean ± SE of five independent experiments (*p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001).
5
Danis et al. PRINS Regulates Immune Responses of Keratinocytes
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1053
single-stranded PRINS RNA and a fluorescently labeled, trun-
cated IL-6 mRNA sequence containing the predicted interacting 
sequence. The ΔPRINS sequence, in which the predicted interac-
tion site to IL-6 was replaced by scrambled sequence, was used 
as a control. As a negative control, a fluorescently labeled DNA 
sequence with no similarity to either PRINS or IL-6 RNAs was 
used. While PRINS exhibited a very high binding affinity to the 
labeled IL-6 mRNA (Figure 5A, Kd = 10.3436 nM), specific bind-
ing for ΔPRINS and the unspecific labeled DNA could not be 
detected (Figure 5B). This result confirms in vitro the specificity 
of the regions predicted in silico (538–622 of PRINS, AK022045 
and 92–204 of IL-6 mRNA, NM_000600.4).
Prins Decreases il-6 expression in 
nheKs through sequence-specific 
interaction
To further validate the functionality of the in  silico predicted 
and in  vitro determined IL-6 mRNA interacting region in the 
PRINS sequence, we performed the overexpression experiments 
in NHEKs with vectors containing the wild-type PRINS or 
ΔPRINS (with scrambled IL-6 binding site) sequences, during 
the combined priming and poly(dA:dT) treatment. IL-6 expres-
sion was not affected by overexpression of ΔPRINS but was, 
in contrast, significantly decreased by PRINS overexpression 
(Figure  6A), and similar tendencies were seen in the amount 
of secreted IL-6 (Figure 6D). To confirm the specificity of this 
region in IL-6 regulation, the expression of CCL-5 was also stud-
ied. CCL-5 expression and secretion decreased similarly both in 
cells overexpressing ΔPRINS and in cells overexpressing PRINS 
(Figures 6B,E). IL-8 expression upon PRINS or ΔPRINS overex-
pression showed a similar tendency to IL-6 expression, although 
significant differences could not be detected (Figures 6C,F). These 
result demonstrated that the binding site in the PRINS sequence 
is essential and specific for the regulation of IL-6 expression.
DiscUssiOn
Due to large-scale gene-expression studies the number of anno-
tated human non-coding RNAs has increased rapidly (24), but 
functional roles have been assigned only to a few of them (25, 26). 
PRINS was one of the first lncRNAs described to be dysregulated 
in a disease, namely in psoriasis (13). PRINS is located in an intron 
of the KIAA1217 gene on the sense strand (27), and, thus, it can 
be considered as a long intronic non-coding RNA. The expression 
of PRINS increases in response to various cellular stressors (14) in 
HaCaT cells, as well as to hypoxia in HK-2 cells (15) suggesting 
that PRINS contributes to the stress response of the cells. Recent 
reports on PRINS showing decreased expression upon inflamma-
tory stimuli in both NHEKs and macrophages (14, 16), and the 
potential interaction between PRINS and the mRNA of CCL-5 
(15) has led us to study its potential contribution to keratinocytes 
immune responses.
FigUre 3 | Overexpression of PRINS regulates the expression and secretion of interleukin-6 (IL-6) and IL-8. In parallel to priming with 5 ng/ml tumor necrosis factor-
α and interferon-γ, normal human epidermal keratinocytes were transfected with a pcDNA3.1(+) vector containing the PRINS cDNA; an empty pcDNA3.1(+) vector 
was used as control. After 24 h, cells were transfected with poly(dA:dT). RNA expression of cytokines IL-6 (a) and IL-8 (B) was detected by real-time RT-PCR. 
Secretion of cytokines IL-6 (c) and IL-8 (D), was detected by ELISA from cell supernatants. Data are presented as mean ± SE of four independent experiments 
(*p ≤ 0.05; **p ≤ 0.01).
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To study keratinocyte immune functions, we applied a treat-
ment with the cytosolic DNA-analog poly(dA:dT), which was 
reported to induce inflammasome activation in these cells (3, 28) 
and induce the expression of several cytokines through a RIG-I-
dependent mechanism in professional immune cells (29). Before 
poly(dA:dT) treatment, a priming with the cytokines TNF-α and 
IFN-γ was applied, which were described to be key elements in 
keratinocyte immune responses (30) and induce a pronounced 
inflammasome activation (4). Our results are in agreement 
with recent reports describing inflammasome activation in 
keratinocytes (3, 4, 28) and IL-6, IL-8, and TNF-α induction 
in canine keratinocytes (6) and human melanocytes (31) upon 
poly(dA:dT) exposition. Priming induced significantly enhanced 
mRNA expression of IL-6 and IL-8. In addition, cytokine secre-
tion significantly increased compared to poly(dA:dT) treatment 
alone. In contrast to cytokine expression, poly(dA:dT) treatment 
decreased PRINS expression in NHEKs in line with previous 
reports in NHEKs and macrophages (14, 16).
PRINS was recently described to potentially interact with the 
CCL-5 mRNA (15), but its function remains to be elucidated. In 
this study, we demonstrate that PRINS overexpression decreases 
the expression of IL-6, IL-8, and CCL-5 in keratinocytes upon 
poly(dA:dT) treatment. In addition, decreased IL-6 expression 
was observed upon PRINS overexpression in UVB-treated 
samples as well (data not shown). Using in silico analysis, regions 
in the PRINS sequence were predicted to interact with CCL-5 
and IL-6 mRNA. As inhibition of transcription by DNA:lncRNA 
triplex formation or posttranscriptional destabilization of the 
mRNA by mRNA–lncRNA duplex formation has been reported 
(25), we analyzed the sequences and found that the interacting 
site on IL-6 spans two exons, indicating an mRNA–lncRNA 
interaction. Moreover, PRINS demonstrated perinuclear localiza-
tion in keratinocytes (32), making it possible to exert its effect 
at the posttranscriptional level. The mRNA–lncRNA interaction 
was validated in vitro: PRINS showed a very high binding affinity 
(Kd = 10.3436 nM) to IL-6 mRNA, and the destruction of the 
predicted binding site abolished the ability of PRINS to bind to 
the IL-6 mRNA. The binding site of PRINS lies within the 5′ UTR 
of the IL-6 mRNA, which is a rare phenomenon. The majority 
(~40%) of lncRNAs bind to the 3′ UTR of their target mRNAs, 
while only around 5% of lncRNAs is able to bind to the 5′ UTR of 
their target (33). The functionality of the mRNA–lncRNA inter-
action was also observed at the cellular level, as overexpression of 
ΔPRINS, in which the IL-6 interacting site is scrambled, did not 
decrease IL-6 levels. Thus, we demonstrated that PRINS is able 
to bind the IL-6 mRNA and this specific interaction destabilizes 
IL-6 expression and secretion in NHEKs.
Similar to IL-6, PRINS overexpression decreased the expres-
sion of IL-8, but no interaction site could be predicted. We 
hypothesize that this is a secondary effect (34); however, we 
cannot exclude the possibility of a yet unknown interaction site 
between PRINS and IL-8 mRNA.
FigUre 5 | PRINS specifically binds to interleukin-6 (IL-6) mRNA. The binding affinity of PRINS (a) and ΔPRINS (B) to IL-6 mRNA was determined by analyzing the 
initial fluorescence enhancement caused by specific binding. The concentration of labeled IL-6 mRNA was constant (10 nM), while the concentration of PRINS and 
ΔPRINS varied from 62 pM to 127 nM.
FigUre 4 | Putative interactions between PRINS long non-coding RNA and chemokine (C-C motif) ligand 5 (CCL-5) and interleukin-6 (IL-6) mRNAs. Schematic 
representation of the in silico predicted interaction sites in the PRINS sequence for the CCL-5 and IL-6 mRNAs (a). PRINS sequences predicted to interact with 
CCL-5 mRNA (B) and IL-6 mRNA (c). Nucleotide positions are given based on the AK022045, NM_000600.4, and NM_002985.2 reference sequences.
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Many lncRNAs which were reported to regulate mRNA 
expression were found to act as primary transcripts for miRNAs 
(35). We have found no evidence that PRINS is cleaved to smaller 
miRNA precursors, but the IL-6 binding site of PRINS is 96% 
similar to the miR5585, which is predicted by TargetMiner to have 
IL-6 mRNA as a target (36). miR5585 is located on Chromosome 
7, whereas PRINS is located on Chromosome 10, so their high 
similarity and overlapping functions might originate from gene 
duplication.
Like many other non-coding RNAs, PRINS seems to have 
multiple cellular functions (37). It binds to nucleophosmin, a 
chaperon protein, and facilitates its transition from the nucleolus 
to the nucleoplasm upon UVB irradiation (32). Additionally, our 
recent results suggest that PRINS is involved with inflammation 
FigUre 6 | The 538–622 nt region of PRINS is required for the regulation of interleukin-6 (IL-6) expression. In parallel to priming with 5 ng/ml tumor necrosis 
factor-α and interferon-γ, normal human epidermal keratinocytes were transfected with a pcDNA3.1(+) vector containing the PRINS cDNA or the ΔPRINS cDNA 
(containing a scrambled version of the IL-6 binding site at positions 538–622 nt); the empty pcDNA3.1(+) vector served as control, after 24 hours cells were 
transfected by poly(dA:dT). Expression of cytokines IL-6 (a), CCL-5 (B), and IL-8 (c) was detected by real-time RT-PCR. Secretion of cytokines IL-6 (D), CCL-5 (e), 
and IL-8 (F) was detected by ELISA from cell supernatants. Nucleotide positions based on the AK022045 reference sequence. Data are presented as mean ± SE of 
three independent experiments (*p ≤ 0.05; **p ≤ 0.01).
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by inhibiting cytokine expression. Based on our current and 
previous findings (13–15), we hypothesize that elevated PRINS 
expression in psoriatic uninvolved epidermis may contribute 
to downregulation of the inflammatory functions in psoriatic 
keratinocytes and maintenance of normal phenotype.
Our studies were performed using a non-professional immune 
cell type, keratinocytes; however, the same mechanisms might 
be also relevant in professional immune cells. Further studies 
on the same PRINS-related cellular events upon additional 
stressors such as UVB or microbial components may widen our 
knowledge on the cellular functions of PRINS and, in general, 
about lncRNAs.
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